Genitourinary system & sexual hormones market revenue in Argentina 2017-2022
In the fourth quarter of 2022, the revenue of the genitourinary system and sexual hormones pharmaceutical industry in Argentina amounted to approximately 20.9 billion Argentine pesos. In the previous quarter, the market revenue for these pharmaceuticals peaked at over 21.2 billion pesos, the highest market revenue registered in the South American country between 2017 and 2022.